Evidence map›Paper›PMID 22757753›Full record

ArticleJournal of neurochemistry2012

A mutation in CLOCK leads to altered dopamine receptor function.

Sade Spencer, Melissa I Torres-Altoro, Edgardo Falcon, Rachel Arey, Marian Marvin, Matthew Goldberg, James A Bibb, Colleen A McClung

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Valproate Reverses Mania-Like Behavior ofNeuropsychiatric disease and treatment · 2021
    Article
  14. Cell-Type-Specific Regulation of Nucleus Accumbens Synaptic Plasticity and Cocaine Reward Sensitivity by the Circadian Protein, NPAS2.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sade SpencerDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
Melissa I Torres-Altoro
Edgardo Falcon
Rachel Arey
Marian Marvin
Matthew Goldberg
James A Bibb
Colleen A McClung
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center · US

Funding

The Role of Cdk5 in AddictionR01DA016672 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI BIBB, JAMES A · 2003 to 2010
$2.5M
Novel Signal Transduction Mechanisms in Learning and MemoryR01MH083711 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI BIBB, JAMES A · 2010 to 2014
$2.0M
Role of The Circadian Clock in the Development and Treatment of Mood DisordersR01MH082876 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI MCCLUNG, COLLEEN A · 2009 to 2013
$1.9M
Addiction-like behavior in models of mood disorders: role of CLOCK and NPAS2R01DA023988 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI MCCLUNG, COLLEEN A · 2009 to 2013
$1.9M
The Regulation of Dopamine Neurotransmission by CDK5R01MH079710 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI BIBB, JAMES A · 2008 to 2011
$1.7M
NMDA RECEPTOR REGULATION IN ADDICTIONR01DA033485 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI BIBB, JAMES A · 2012 to 2016
$1.6M
The role of dopaminergic transmission in the development of manic-like behaviorsF31MH090683 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI SPENCER, SADE MONIQUE · 2010 to 2011
$52k
NIDA NIH HHS DA016672NIDA NIH HHS DA023988NIDA NIH HHS DA033485NIDA NIH HHS R01 DA016672NIDA NIH HHS R01 DA023988NIDA NIH HHS R01 DA033485NIMH NIH HHS F31 MH090683NIMH NIH HHS MH082876NIMH NIH HHS MH083711NIMH NIH HHS MH090683NIMH NIH HHS MH79710NIMH NIH HHS R01 MH079710NIMH NIH HHS R01 MH082876NIMH NIH HHS R01 MH083711
6 · The paper itself

Abstract

Mice with a mutation in the Clock gene (ClockΔ19) have a number of behavioral phenotypes that suggest alterations in dopaminergic transmission. These include hyperactivity, increased exploratory behavior, and increased reward value for drugs of abuse. However, the complex changes in dopaminergic transmission that underlie the behavioral abnormalities in these mice remain unclear. Here we find that a loss of CLOCK function increases dopamine release and turnover in striatum as indicated by increased levels of metabolites HVA and DOPAC, and enhances sensitivity to dopamine receptor antagonists. Interestingly, this enlarged dopaminergic tone results in downstream changes in dopamine receptor (DR) levels with a surprising augmentation of both D1- and D2-type DR protein, but a significant shift in the ratio of D1 : D2 receptors in favor of D2 receptor signaling. These effects have functional consequences for both behavior and intracellular signaling, with alterations in locomotor responses to both D1-type and D2-type specific agonists and a blunted response to cAMP activation in the ClockΔ19 mutants. Taken together, these studies further elucidate the abnormalities in dopaminergic transmission that underlie mood, activity, and addictive behaviors.

Indexed as

3,4-Dihydroxyphenylacetic AcidAnalysis of VarianceAnimalsCLOCK ProteinsColforsinCorpus StriatumDopamineDopamine AgentsDose-Response Relationship, DrugGene Expression RegulationHomovanillic AcidIn Vitro TechniquesMiceMice, TransgenicMotor ActivityMutation3,4-Dihydroxyphenylacetic AcidClock protein, mouseCLOCK ProteinsColforsinDopamineDopamine AgentsHomovanillic AcidReceptors, Dopamine

Identifiers

PMID22757753
PMCPMC3438377
OpenAlexW1537372272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.